Penile intraepithelial neoplasia: results of photodynamic therapy

John Paoli1, Annika Ternesten Bratel, Gun-Britt Löwhagen

  • 1Department of Dermatology and Venereology, Sahlgrenska University Hospital, SE-41345 Göteborg, Sweden. john.paoli@vgregion.se

Acta Dermato-Venereologica
|September 7, 2006
PubMed

Insights

Photodynamic therapy shows promise for treating penile intraepithelial neoplasia in men over 40. While initial responses were observed in 70% of patients, further research is needed to establish definitive treatment guidelines.

Area of Science:

  • Oncology
  • Dermatology
  • Urology

Background:

  • Penile intraepithelial neoplasia (PIN) often presents challenges with treatment response and recurrence.
  • Photodynamic therapy (PDT) is an emerging treatment option for PIN.
  • Limited data exists on PDT efficacy in older male populations.

Purpose of the Study:

  • To evaluate the outcomes of photodynamic therapy for penile intraepithelial neoplasia in men over 40 years of age.
  • To assess treatment response, recurrence rates, and progression to invasive cancer.

Main Methods:

  • A study involving ten male patients aged 42-82 years with histopathologically confirmed PIN.
  • Treatment administered using photodynamic therapy.
  • Follow-up to monitor lesion response, recurrence, and development of invasive cancer.

Main Results:

  • Initial response to PDT was observed in 7 out of 10 patients.
  • Four patients achieved complete clearance with no recurrence over a mean follow-up of 35 months (mean 4.5 treatments).
  • Three patients experienced recurrence; however, no patient progressed to invasive penile cancer during a mean follow-up of 46.5 months.

Conclusions:

  • Photodynamic therapy represents a viable alternative treatment for penile intraepithelial neoplasia in men over 40.
  • Prospective randomized trials are necessary to establish standardized therapeutic guidelines for PDT in PIN management.

Related Concept Videos